GlassScriptPhysician profile
Barbara R Porter
NPI 1689669749
$2,055.48
in general payments reported to CMS, 2019-2025
12 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $199 · 2021: $205 · 2022: $488 · 2023: $305 · 2024: $390 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $645.53 | 2019-2024 | Acuvue |
| Oyster Point Pharma, INC. | $371.82 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $362.87 | 2023-2025 | Infuse, Xiidra, Miebo |
| Tarsus Pharmaceuticals, INC. | $223.34 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $205.10 | 2020-2023 | Cequa |
| Alcon Vision LLC | $88.78 | 2019-2025 | Precision7, Simbrinza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $54.32 | 2020-2021 | |
| Coopervision INC. | $53.35 | 2023-2024 | Clariti Contact Lens, Myday Contact Lens |
| Dompe US, INC. | $15.75 | 2025 | Oxervate |
| Optos, INC. | $12.26 | 2022 | |
| Abb Con-Cise Optical Group LLC | $11.89 | 2019 | |
| Biotissue Holdings INC. | $10.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.